Shares of PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $23.78, but opened at $24.49. PureTech Health shares last traded at $24.50, with a volume of 800 shares.
PureTech Health Trading Up 2.0 %
The business’s fifty day simple moving average is $28.21 and its two-hundred day simple moving average is $26.24.
Hedge Funds Weigh In On PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. AWM Investment Company Inc. purchased a new position in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 6,900 shares of the company’s stock, valued at approximately $197,000. Institutional investors and hedge funds own 0.04% of the company’s stock.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Recommended Stories
- Five stocks we like better than PureTech Health
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Top Biotech Stocks: Exploring Innovation Opportunities
- MarketBeat Week in Review – 6/24 – 6/28
- Energy and Oil Stocks Explained
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.